Published in Obstet Gynecol on June 01, 1993
The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis (2009) 2.56
Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial. J Infect Dis (2008) 2.21
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Ann Intern Med (2008) 1.59
A novel molecular microbiologic technique for the rapid diagnosis of microbial invasion of the amniotic cavity and intra-amniotic infection in preterm labor with intact membranes. Am J Reprod Immunol (2014) 1.32
The complex vaginal flora of West African women with bacterial vaginosis. PLoS One (2011) 1.13
Emerging Sexual Health Issues Among Women Who Have Sex with Women. Curr Infect Dis Rep (2012) 1.02
Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial. PLoS Clin Trials (2007) 1.01
Bacterial vaginosis: an overview for 2009. Rev Obstet Gynecol (2009) 0.99
Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infect Dis Obstet Gynecol (2001) 0.86
A pilot clinical trial comparing an acid-buffering formulation (ACIDFORM gel) with metronidazole gel for the treatment of symptomatic bacterial vaginosis. Br J Clin Pharmacol (2006) 0.82
Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis. Infect Dis Obstet Gynecol (1995) 0.81
Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome (2016) 0.80
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Sex Transm Dis (2015) 0.79
Metronidazole vaginal gel 0.75% (MetroGel-Vaginal): a brief review. Infect Dis Obstet Gynecol (1998) 0.78
Comparative study of intravaginal metronidazole and triple-sulfa therapy for bacterial vaginosis. Infect Dis Obstet Gynecol (1996) 0.77
Bacterial vaginosis and trichomoniasis: epidemiology and management of recurrent disease. Infect Dis Obstet Gynecol (1995) 0.75
Polyethylene glycol-based hydrogels for controlled release of the antimicrobial subtilosin for prophylaxis of bacterial vaginosis. Antimicrob Agents Chemother (2014) 0.75
Bacterial biota of women with bacterial vaginosis treated with lactoferrin: an open prospective randomized trial. Microb Ecol Health Dis (2017) 0.75
Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group. N Engl J Med (1995) 8.89
Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis (1997) 6.64
A case-control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N Engl J Med (1988) 5.32
Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med (1975) 4.99
Independent associations of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA (1986) 4.62
Relationships of vaginal Lactobacillus species, cervical Chlamydia trachomatis, and bacterial vaginosis to preterm birth. Obstet Gynecol (1988) 4.23
A review of premature birth and subclinical infection. Am J Obstet Gynecol (1992) 3.76
Preterm labor associated with subclinical amniotic fluid infection and with bacterial vaginosis. Obstet Gynecol (1986) 3.67
The normal vaginal flora, H2O2-producing lactobacilli, and bacterial vaginosis in pregnant women. Clin Infect Dis (1993) 3.32
Bacterial vaginosis as a risk factor for post-cesarean endometritis. Obstet Gynecol (1990) 3.28
Control of the microbial flora of the vagina by H2O2-generating lactobacilli. J Infect Dis (1991) 3.17
Comparison of methods for diagnosing bacterial vaginosis among pregnant women. J Clin Microbiol (1989) 3.06
Earth, motherhood, and the intrauterine device. Fertil Steril (1992) 2.67
Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infections. JAMA (1982) 2.55
Increased frequency of serum antibodies to Chlamydia trachomatis in infertility due to distal tubal disease. Lancet (1982) 2.38
Criteria for diagnosis and grading of salpingitis. Obstet Gynecol (1983) 2.37
The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labor. Obstet Gynecol (1992) 2.32
Pathogenesis of acute pelvic inflammatory disease: role of contraception and other risk factors. Am J Obstet Gynecol (1977) 2.31
Evaluation of the rapid CORYNE identification system for Corynebacterium species and other coryneforms. J Clin Microbiol (1992) 2.24
Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynecol (1996) 2.16
The relationship of hydrogen peroxide-producing lactobacilli to bacterial vaginosis and genital microflora in pregnant women. Obstet Gynecol (1992) 2.15
The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet Gynecol (1993) 2.12
Association between vaginal douching and acute pelvic inflammatory disease. JAMA (1990) 2.11
Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA (1990) 2.02
High prevalence of cervical dysplasia in STD clinic patients warrants routine cytologic screening. Am J Public Health (1980) 1.99
Endometrial histopathology in patients with culture-proved upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol (1990) 1.88
Macromolecule synthesis in a mutant of Saccharomyces cerevisiae inhibited by S-adenosyimethionine. Mol Gen Genet (1976) 1.82
Curved anaerobic bacteria in bacterial (nonspecific) vaginosis and their response to antimicrobial therapy. J Infect Dis (1983) 1.77
Vaginal Bacteroides species are associated with an increased rate of preterm delivery among women in preterm labor. J Infect Dis (1991) 1.77
Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol (1996) 1.72
Histopathology of endocervical infection caused by Chlamydia trachomatis, herpes simplex virus, Trichomonas vaginalis, and Neisseria gonorrhoeae. Hum Pathol (1990) 1.58
Biochemical diagnosis of vaginitis: determination of diamines in vaginal fluid. J Infect Dis (1982) 1.58
Gonococcal salpingitis is less likely to recur with Neisseria gonorrhoeae of the same principal outer membrane protein antigenic type. Am J Obstet Gynecol (1980) 1.56
The role of bacterial vaginosis as a cause of amniotic fluid infection, chorioamnionitis and prematurity--a review. Arch Gynecol Obstet (1990) 1.54
Vaginal indicators of amniotic fluid infection in preterm labor. Obstet Gynecol (2001) 1.50
Depomedroxyprogesterone-induced hypoestrogenism and changes in vaginal flora and epithelium. Obstet Gynecol (2000) 1.50
Light and electron microscopic study of Chlamydia trachomatis infection of the uterine cervix. J Infect Dis (1975) 1.48
Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in premature labor. Clin Infect Dis (1997) 1.48
Microbiologic causes and neonatal outcomes associated with chorioamnion infection. Am J Obstet Gynecol (1991) 1.44
Use of antibiotics to prevent preterm birth. Am J Obstet Gynecol (1997) 1.44
Epithelial cell layer thickness and immune cell populations in the normal human vagina at different stages of the menstrual cycle. Am J Obstet Gynecol (2000) 1.44
Determinants of cervical ectopia and of cervicitis: age, oral contraception, specific cervical infection, smoking, and douching. Am J Obstet Gynecol (1995) 1.40
Bacteriology of the vagina. Scand J Urol Nephrol Suppl (1984) 1.36
Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group. Obstet Gynecol (1991) 1.36
Erythromycin ointment for ocular prophylaxis of neonatal chlamydial infection. JAMA (1980) 1.36
Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm. Obstet Gynecol (1998) 1.34
Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease. Am J Obstet Gynecol (1986) 1.33
Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1998) 1.32
Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin. Ann Intern Med (1986) 1.30
Puerperal infectious morbidity: relationship to route of delivery and to antepartum Chlamydia trachomatis infection. Am J Obstet Gynecol (1980) 1.26
Risk factors for preterm premature rupture of fetal membranes: a multicenter case-control study. Am J Obstet Gynecol (1990) 1.25
Clinical manifestations of genital infection due to Chlamydia trachomatis in women: differences related to serovar. Clin Infect Dis (1994) 1.24
Bacterial vaginosis during pregnancy. An association with prematurity and postpartum complications. Scand J Urol Nephrol Suppl (1984) 1.22
The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group. J Infect Dis (1995) 1.22
Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol (1985) 1.21
The role of Gardnerella vaginalis in nonspecific vaginitis. Clin Obstet Gynecol (1981) 1.21
Salpingitis: overview of etiology and epidemiology. Am J Obstet Gynecol (1980) 1.21
Endometrial cultures obtained by a triple-lumen method from afebrile and febrile postpartum women. J Infect Dis (1986) 1.20
Acute pelvic inflammatory disease: current concepts of pathogenesis, etiology, and management. Clin Obstet Gynecol (1975) 1.19
The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes. Clin Infect Dis (1995) 1.18
Early postpartum endometritis: the role of bacteria, genital mycoplasmas, and Chlamydia trachomatis. Obstet Gynecol (1989) 1.17
Chlamydia trachomatis infection in Fitz-Hugh-Curtis syndrome. Am J Obstet Gynecol (1980) 1.16
Gardnerella vaginalis and anaerobic bacteria in the etiology of bacterial (nonspecific) vaginosis. Scand J Infect Dis Suppl (1983) 1.15
Nonspecific vaginosis. Scand J Infect Dis Suppl (1981) 1.15
C-reactive protein in normal pregnancy. Obstet Gynecol (1991) 1.14
Polymicrobial early postpartum endometritis with facultative and anaerobic bacteria, genital mycoplasmas, and Chlamydia trachomatis: treatment with piperacillin or cefoxitin. J Infect Dis (1986) 1.13
Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease. J Infect Dis (1997) 1.12
Antepartum cultures for Ureaplasma urealyticum are not useful in predicting pregnancy outcome. The Vaginal Infections and Prematurity Study Group. Am J Obstet Gynecol (1991) 1.11
Genital flora in pregnancy and its association with intrauterine growth retardation. J Clin Microbiol (1994) 1.09
Persistent neuropsychological sequelae of toxic shock syndrome. Ann Intern Med (1982) 1.06
A dose-duration study of metronidazole for the treatment of nonspecific vaginosis. Scand J Infect Dis Suppl (1983) 1.06
Amniotic fluid infection, cytokines, and adverse outcome among infants at 34 weeks' gestation or less. Obstet Gynecol (2001) 1.03
Bacteria in the transfer catheter tip influence the live-birth rate after in vitro fertilization. Fertil Steril (2000) 1.03
The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast. Am J Obstet Gynecol (1995) 1.02
Infertility following pelvic inflammatory disease. Infect Dis Obstet Gynecol (1999) 1.02
Vaginal infection. Clin Obstet Gynecol (1983) 1.02
Outcome of the Vaginal Infections and Prematurity Study: results of a clinical trial of erythromycin among pregnant women colonized with group B streptococci. Am J Obstet Gynecol (1995) 1.00
Clinical and microbiological correlates of vaginal trichomoniasis during pregnancy. The Vaginal Infections and Prematurity Study Group. Clin Infect Dis (1996) 1.00
Effects of human immunodeficiency virus 1 infection on microbial origins of pelvic inflammatory disease and on efficacy of ambulatory oral therapy. Am J Obstet Gynecol (1999) 1.00
Amoxicillin treatment of bacterial vaginosis during pregnancy. Obstet Gynecol (1991) 0.99
Pelvic inflammatory disease. Key treatment issues and options. JAMA (1991) 0.98
Risk assessment, symptoms, and signs as predictors of vulvovaginal and cervical infections in an urban US STD clinic: implications for use of STD algorithms. Sex Transm Infect (1998) 0.98
Vaginal redox potential in bacterial vaginosis (nonspecific vaginitis). J Infect Dis (1985) 0.98
Changes in the background activity of the electroencephalogram according to age. Electroencephalogr Clin Neurophysiol (1980) 0.97
Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med (2000) 0.97
Comparison of ophthalmic silver nitrate solution and erythromycin ointment for prevention of natally acquired Chlamydia trachomatis. Sex Transm Dis (1988) 0.97
Antibodies to the chlamydial 60 kd heat-shock protein are associated with laparoscopically confirmed perihepatitis. Am J Obstet Gynecol (1997) 0.96
A survey of practices in infectious diseases by obstetrician-gynecologists. Obstet Gynecol (1994) 0.95
Acute pelvic inflammatory disease: etiology, risk factors and pathogenesis. Clin Obstet Gynecol (1976) 0.95
Amniotic fluid tumor necrosis factor-alpha and the risk of respiratory distress syndrome among preterm infants. Am J Obstet Gynecol (1997) 0.94
Isolation of mycoplasmas and bacteria from the blood of postpartum women. Am J Obstet Gynecol (1982) 0.94
Development of wound infections among women undergoing cesarean section. Obstet Gynecol (1988) 0.94
Epidemiology and diagnosis of acute pelvic inflammatory disease. Obstet Gynecol (1980) 0.93
Bacteremia shortly after placental separation during cesarean delivery. Obstet Gynecol (1996) 0.92
Microbiology and treatment of late postpartum endometritis. Obstet Gynecol (1986) 0.92
Microbiological, epidemiological and clinical correlates of vaginal colonisation by Mobiluncus species. Genitourin Med (1991) 0.91
Upper genital tract isolates at delivery as predictors of post-cesarean infections among women receiving antibiotic prophylaxis. Obstet Gynecol (1991) 0.90